Business Context and Reporting Period
Company: Trio-Tech International
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended June 28, 1996
Business Overview: The Company designs, manufactures, and markets environmental testing equipment for semiconductor devices and operates testing facilities globally. Key operations include manufacturing in the U.S., Singapore, and Ireland, and testing services in the U.S., Southeast Asia, and Europe. The Company also distributes test equipment in Singapore.
Key Financial Metrics
| Metric (in thousands) | Fiscal 1996 | Fiscal 1995 |
|---|---|---|
| Net Sales | $23,185 | $19,488 |
| Gross Profit | $8,520 | $6,744 |
| Gross Margin | 36.7% | 34.6% |
| Operating Income | $2,712 | $1,547 |
| Net Income | $806 | $570 |
| Net Income Per Share (Diluted) | $0.63 | $0.46 |
| Working Capital | $3,591 | $1,689 |
| Total Assets | $17,416 | $12,646 |
| Long-Term Debt | $688 | $597 |
| Cash and Equivalents | $5,228 | $1,227 |
Note: Cash and Equivalents includes Cash ($2,114) and Certificates of Deposit ($3,114).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 19.0% to $23.185 million, driven primarily by a 23.2% increase in Far East operations (Singapore and Malaysia) due to higher testing volumes.
- Profitability: Net income rose 41.4% to $806,000. Gross margin improved to 36.7% from 34.6% due to cost controls.
- Operating Expenses: Increased 11.8% to $5.808 million but decreased as a percentage of sales from 26.7% to 25.1%.
- Liquidity: Working capital improved significantly from $1.689 million to $3.591 million, supported by increased sales and improved cash collections.
- Interest Expense: Decreased from $183,000 to $141,000 due to reduced interest rates and lower average debt balances.
Outlook, Risks, and Unusual Items
- Backlog: Total backlog decreased to $4.618 million from $5.202 million, primarily due to a drop in testing service backlog. Management does not anticipate significant cancellations.
- Legal Proceedings: The Company is a defendant in a civil action regarding soil and groundwater contamination at the North Hollywood Superfund Site. The action is currently stayed. Management believes the outcome will not materially affect financial position.
- Unusual Items: The 1994 fiscal year included a $1.751 million extraordinary gain from the extinguishment of debt. No such items were reported in 1996.
- Customer Concentration: Two customers accounted for 14% and 20% of sales in 1996. The Company relies on independent testing labs and semiconductor manufacturers.
- Supply Chain Risks: The Company relies on specific suppliers for Fluorinert and Krypton 85 (a radioactive gas used in leak testing). While no difficulties have been experienced, future supply disruptions are a risk.
- Outlook: Management believes operations will be funded through existing working capital and lines of credit over the next twelve months.
Investor Verification Checklist
- Revenue Mix: Verify the sustainability of the 55% revenue contribution from testing services, which drove the year-over-year growth.
- Customer Concentration: Assess the risk associated with the top two customers representing 34% of total sales.
- Legal Exposure: Monitor the status of the North Hollywood Superfund litigation, despite the current stay.
- Foreign Operations: Review the performance of Southeast Asian subsidiaries, which generated the majority of revenue and operating profit.
- Debt Covenants: Confirm compliance with debt covenants, specifically the minimum net worth requirement of $2.4 million for the Singapore subsidiary.